David Michael Clark - Net Worth and Insider Trading
David Michael Clark Net Worth
The estimated net worth of David Michael Clark is at least $3 Million dollars as of 2024-11-05. David Michael Clark is the Chief People Officer of Amicus Therapeutics Inc and owns about 253,664 shares of Amicus Therapeutics Inc (FOLD) stock worth over $3 Million. Details can be seen in David Michael Clark's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Michael Clark has not made any transactions after 2024-02-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Michael Clark
David Michael Clark Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Michael Clark owns 1 companies in total, including Amicus Therapeutics Inc (FOLD) .
Click here to see the complete history of David Michael Clark’s form 4 insider trades.
Insider Ownership Summary of David Michael Clark
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2024-02-15 | Chief People Officer |
David Michael Clark Latest Holdings Summary
David Michael Clark currently owns a total of 1 stock. David Michael Clark owns 253,664 shares of Amicus Therapeutics Inc (FOLD) as of February 15, 2024, with a value of $3 Million.
Latest Holdings of David Michael Clark
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2024-02-15 | 253,664 | 11.38 | 2,886,696 |
Holding Weightings of David Michael Clark
David Michael Clark Form 4 Trading Tracker
According to the SEC Form 4 filings, David Michael Clark has made a total of 7 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Amicus Therapeutics Inc is the sale of 4,427 shares on February 15, 2024, which brought David Michael Clark around $61,978.
Insider Trading History of David Michael Clark
- 1
David Michael Clark Trading Performance
David Michael Clark Ownership Network
Ownership Network List of David Michael Clark
Ownership Network Relation of David Michael Clark
David Michael Clark Owned Company Details
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
David Michael Clark is the Chief People Officer of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and General Counsel & Corp. Secy Ellen Rosenberg .
Amicus Therapeutics Inc (FOLD) Insider Trades Summary
Over the past 18 months, David Michael Clark made 2 insider transaction in Amicus Therapeutics Inc (FOLD) with a net sale of 14,537. Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 333,235 shares made by John F Crowley , a net sale of 224,861 shares made by Bradley L Campbell , and a net sale of 95,000 shares made by Ellen Rosenberg .
In summary, during the past 3 months, insiders sold 22,500 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 22,500 shares. During the past 18 months, 795,880 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 795,880 shares.
Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
David Michael Clark Mailing Address
Above is the net worth, insider trading, and ownership report for David Michael Clark. You might contact David Michael Clark via mailing address: 1 Cedar Brook Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
